1To record the DRC of agonist using suitable isolated tissues preparation.
2To study the effects of antagonist/potentiating agents on DRC of agonist using suitable isolated tissue preparation.
3To determine to the strength of unknown sample by matching bioassay by using suitable tissue preparation.
4To determine to the strength of unknown sample by interpolation bioassay by using suitable tissue preparation
5To determine to the strength of unknown sample by bracketing bioassay by using suitable tissue preparation
6To determine to the strength of unknown sample by multiple point bioassay by using suitable tissue preparation.
7Estimation of PA2 values of various antagonists using suitable isolated tissue preparations.
8To study the effects of various drugs on isolated heart preparations
9Recording of rat BP, heart rate and ECG.
10Recording of rat ECG
11Drug absorption studies by averted rat ileum preparation.
12Acute oral toxicity studies as per OECD guidelines.
13Acute dermal toxicity studies as per OECD guidelines.
14Repeated dose toxicity studies - Serum biochemical, haematological, urine analysis, functional observation tests and histological studies.
15Drug mutagenicity study using mice bone-marrow chromosomal aberration test.
16Protocol design for clinical trial. (3 Nos.)
17Design of ADR monitoring protocol.
18In-silico docking studies. (2 Nos.)
19In-silico pharmacophore based screening.
20In-silico QSAR studies.
21ADR reporting